SPECT in Medical Technology

Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program

...ls, it would be expected that these patients also have fewer DATs than do patients without Parkinsonian Syndromes. Altropane used in conjunction with spect imaging could be a useful test to aid in the early diagnosis of Parkinsonian Syndromes (PS) in patients with tremor for whom the clinical diagnosis is...

What is the Optimal Method of Ischemia Evaluation in WomeN: Preliminary Data from the WOMEN Study

...y Status (DASI) questionnaire. Women were randomized to either electrocardiogram exercise tolerance testing (ETT) alone or ETT with Tc-99m tetrofosmin spect myocardial perfusion imaging. Ongoing results are monitored by a Data Safety and Monitoring Board with all events adjudicated. Major adverse cardiac e...

Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease

... this duration, no change in patients' cognitive scores was observed and there was no change in levels of brain amyloid beta plaque as measured by the spect tracer. In addition to the increase in the two major forms of the amyloid beta protein seen in blood and cerebrospinal fluid, an increase in the two o...

Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD

...sent around the brain and spinal cord). In an optional sub-study, 24 Alzheimer's patients and 13 volunteers underwent a type of brain imaging known as spect using a tracer (known as IMPY) that measures the amount of amyloid plaque present in the brain. Measures of symptom severity were obtained in all AD p...

Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation

...f Alzheimer's over 19 months. Imaging results from spect and PET scans were collected at baseline and after.... The researchers added that brain imaging using spect and PET confirmed the clinical trial results. spect measures regional cerebral blood flow (rCBF) which...

FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)

...ET imaging compared to SPECT," said Dr. Kundakovic, President of FluoroPharma. "There is tremendous opportunity for BFPET, as a PET alternative in the spect dominated myocardial perfusion imaging market. The use of BFPET in conjunction with PET technology holds the promise to better quality CAD diagnosis."...

Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program

... distinguish Parkinsonian Syndrome tremors from non- Parkinsonian tremor: non- Parkinsonian patients would have more ALTROPANE- binding visible in the spect image, while Parkinsonian patients would have less. There are several conditions that are considered Parkinsonian Syndromes. Parkinson's Disease is ...

Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program

...ted that these patients also have fewer DATs than do patients without Parkinsonian Syndromes. Thus, we believe that ALTROPANE used in conjunction with spect imaging could be a useful test to distinguish Parkinsonian Syndrome tremors from non- Parkinsonian tremor: non-Parkinsonian patients would have more A...

Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio

...nostic SPECT-CT using Siemens Symbia TruePoint(TM) SPECT-CT imaging systems combines anatomical clarity obtained from CT with functional imaging using spect lymphoscintigraphy for accurate localization of sentinel nodes. This information is then used for biopsy to evaluate for nodal metastases. The Biogr...

New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting

...Imaging Clinics, Houston, Texas (Abstract No. 2103, Monday June 4, 2007, 2:30 PM) "Use of SPECT/CT in tumor localization: SPECT/CT versus planar and spect imaging in tumor localization" by Levi, et al. Florida Hospital College of Health Sciences, Orlando, Florida (Abstract No. 2228, Monday, June 4, 2007,...